AU2002223743A1 - Means for detecting pathological transformation of the APP protein and their uses - Google Patents

Means for detecting pathological transformation of the APP protein and their uses

Info

Publication number
AU2002223743A1
AU2002223743A1 AU2002223743A AU2002223743A AU2002223743A1 AU 2002223743 A1 AU2002223743 A1 AU 2002223743A1 AU 2002223743 A AU2002223743 A AU 2002223743A AU 2002223743 A AU2002223743 A AU 2002223743A AU 2002223743 A1 AU2002223743 A1 AU 2002223743A1
Authority
AU
Australia
Prior art keywords
app protein
detecting pathological
pathological transformation
transformation
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002223743A
Other versions
AU2002223743B2 (en
Inventor
Andre Delacourte
Nicolas Sergeant
Dorothee Vanuxeem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0014143A external-priority patent/FR2816411B1/en
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU2002223743A1 publication Critical patent/AU2002223743A1/en
Application granted granted Critical
Publication of AU2002223743B2 publication Critical patent/AU2002223743B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002223743A 2000-11-03 2001-11-05 Means for detecting pathological transformation of the APP protein and their uses Ceased AU2002223743B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0014143A FR2816411B1 (en) 2000-11-03 2000-11-03 MEANS FOR DETECTING THE PATHOLOGICAL TRANSFORMATION OF THE APP PROTEIN AND THEIR APPLICATIONS
FR00/14143 2000-11-03
PCT/FR2001/003410 WO2002037118A1 (en) 2000-11-03 2001-11-05 Means for detecting pathological transformation of the app protein and their uses

Publications (2)

Publication Number Publication Date
AU2002223743A1 true AU2002223743A1 (en) 2002-07-18
AU2002223743B2 AU2002223743B2 (en) 2007-01-11

Family

ID=8856055

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2374302A Pending AU2374302A (en) 2000-11-03 2001-11-05 Means for detecting pathological transformation of the app protein and their uses
AU2002223743A Ceased AU2002223743B2 (en) 2000-11-03 2001-11-05 Means for detecting pathological transformation of the APP protein and their uses

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2374302A Pending AU2374302A (en) 2000-11-03 2001-11-05 Means for detecting pathological transformation of the app protein and their uses

Country Status (13)

Country Link
US (1) US7723117B2 (en)
EP (1) EP1330656B1 (en)
JP (1) JP4294953B2 (en)
AT (1) ATE392620T1 (en)
AU (2) AU2374302A (en)
CA (1) CA2427604A1 (en)
CY (1) CY1108182T1 (en)
DE (1) DE60133661T2 (en)
DK (1) DK1330656T3 (en)
ES (1) ES2305126T3 (en)
FR (1) FR2816411B1 (en)
PT (1) PT1330656E (en)
WO (1) WO2002037118A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094064A1 (en) * 2003-11-19 2006-05-04 Sandip Ray Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
EP2211183B1 (en) * 2003-11-19 2013-03-06 Satoris, Inc. Method for diagnosis and monitoring of Alzheimer's disease
WO2006051489A1 (en) 2004-11-10 2006-05-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
US20090099062A1 (en) * 2007-05-31 2009-04-16 Ethan Lee Pyrvinium For The Treatment of Cancer
DE202007015863U1 (en) * 2007-11-12 2009-03-26 Melitta Haushaltsprodukte Gmbh & Co. Kommanditgesellschaft Filter paper insert
KR20100105776A (en) 2008-01-18 2010-09-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Methods of detecting signatures of disease or conditions in bodily fluids
CA2784527A1 (en) 2009-12-16 2011-06-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) 7-chloro-quinolin-4-amine compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs
CA2806291C (en) 2010-07-23 2023-08-29 President And Fellows Of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
CA2806293A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
CA2806310A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting diseases or conditions using phagocytic cells
US20130096552A1 (en) * 2011-10-14 2013-04-18 Christopher L. Brace Hydrodissection Material with Reduced Migration
MX2014015434A (en) 2012-06-15 2015-07-14 Harry Stylli Methods of detecting diseases or conditions using circulating diseased cells.
WO2014164366A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting cancer
AU2014235854B2 (en) 2013-03-21 2019-04-11 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
ES2672993T3 (en) 2015-10-27 2018-06-19 Eupraxia Pharmaceuticals Inc. Sustained release formulations of local anesthetics
US11397188B2 (en) * 2017-03-30 2022-07-26 Board Of Regents, The University Of Texas System Method of detecting an APP Alzheimer's disease marker peptide in patients with Alzheimer's disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234814A (en) * 1989-06-01 1993-08-10 Du Pont Merck Pharmaceutical Company Diagnostic assay for alzheimer's disease
AU8215391A (en) * 1990-06-29 1992-01-23 Case Western Reserve University Diagnostic and prognostic methods based on soluble derivatives of the beta amyloid protein precursor
CA2086165A1 (en) * 1992-04-09 1993-10-10 Paul P. Tamburini Diagnostic assay for alzheimer's disease based on the proteolysis of alzheimer's precursor protein
US5441870A (en) * 1992-04-15 1995-08-15 Athena Neurosciences, Inc. Methods for monitoring cellular processing of β-amyloid precursor protein
WO1994007144A1 (en) 1992-09-21 1994-03-31 United States Of America, As Represented By The Secretary, Department Of Health And Human Services A method of screening compounds and methods for treating alzheimer's disease
US6114133A (en) * 1994-11-14 2000-09-05 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)

Similar Documents

Publication Publication Date Title
AU2001288249A1 (en) Biosensors and methods for their use
AU2001232799A1 (en) Protein c derivatives
AU2002223743A1 (en) Means for detecting pathological transformation of the APP protein and their uses
AU2001249444A1 (en) Methods and compositions for the simultaneous detection of multiple analytes
AU2001267428A1 (en) Direct detection of individual molecules
AU2001286721A1 (en) Human interleukin-four induced protein
AU2001296466A1 (en) Kini-3 motor protein and methods for its use
AU2001281002A1 (en) Motor proteins and methods for their use
AU2001274566A1 (en) Novel protein and dna thereof
AUPQ015299A0 (en) Ph probe
AU2001283207A1 (en) Novel motor proteins and methods for their use
AU2001266961A1 (en) Novel motor proteins and methods for their use
AU2136401A (en) P450rai-2 and related proteins
AU2001287007A1 (en) Reagents and methods for the diagnosis of cmv dissemination
AU2001244863A1 (en) Apoptin-associating protein
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001264726A1 (en) Novel motor proteins and methods for their use
AU2001259240A1 (en) Novel stmst protein and nucleic acid mocecules and uses therefor
AU2001267699A1 (en) Testing of leather
AU2001297707A1 (en) Motor proteins and methods for their use
AU2002224774A1 (en) Human phospholipase a2-like enzyme
AU2002222146A1 (en) Reagents and methods for use inn the detection of analytes
AU2813700A (en) Protein assay
AU2001274563A1 (en) Novel polypeptide and its dna
AU2001240017A1 (en) Human enzyme molecules